Gérard Flesch - Concepedia

Author

Gérard Flesch

Novartis (Switzerland)

Also Known As

G Flesch, G. Flesch, G??rard Flesch, Gerard Flesch, Gérard Flesch, Patrick Brunel

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Hvidovre Hospital

About

Gérard Flesch is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	861
2	Health Sciences	1	1	131
3	Social Sciences	1	1	40
4	Anesthesia	1	1	40
5	Chemistry	1	1	35

Gérard Flesch

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy Gábor Barcs, Edwin Walker, Christian E. Elger, Epilepsia	2000	225
Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man Gérard Flesch, Philipp Müller, Peter Lloyd European Journal of Clinical Pharmacology HypertensionPharmacological StudyMedicineAbsolute BioavailabilityCardiovascular Pharmacology	1997	199
Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose Felix Waldmeier, Gérard Flesch, P. Mu ̈ller, Xenobiotica Plasma RadioactivityLow Radioactivity LevelsPharmacotherapyTotal ExcretionMolecular Pharmacology	1997	131
Overview of the Clinical Pharmacokinetics of Oxcarbazepine Gérard Flesch Clinical Drug Investigation MedicinePharmacotherapyClinical PharmacokineticsPharmacologyPharmacokinetics	2004	110
Pharmacokinetics of valsartan in patients with liver disease L Brookman, Paul Rolan, I S Benjamin, Clinical Pharmacology & Therapeutics	1997	93
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia [see comments] VR Gordeuk, PE Thuma, GM Brittenham, Blood	1992	90
Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects P. M�ller, Gérard Flesch, Marc de Gasparo, European Journal of Clinical Pharmacology Molecular PharmacologyHypertensionNormotensive SubjectsSteady StateAntihypertensive Therapy	1997	70
Pharmacokinetics of Pamidronate in Patients With Bone Metastases Serge Leyvraz, U Hess, Gérard Flesch, JNCI Journal of the National Cancer Institute	1992	68
Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection Gérard Flesch, Suzanne Hauffe Journal of Chromatography B Biomedical Sciences and Applications Fluorescence DetectionMedicineBisphosphonate Pamidronate DisodiumAnalytical ChemistryLiquid Chromatography	1989	59
Intravenous Pamidronate for Treatment of Reflex Sympathetic Dystrophy During Breast Feeding Kerry Siminoski, Avril A. Fitzgerald, Gérard Flesch, Journal of Bone and Mineral Research	2000	47

Page 1